LI-RADS 用于肝细胞癌 MR 诊断:主要征象与辅助征象的表现
本回顾性研究纳入 102 例患者共 275 个病灶(其中 113 个肝细胞癌),由两名放射科医师独立评估 LI-RADS 2014 版主要征象与辅助征象并分类。结果显示联合辅助征象与主要征象可提高肝细胞癌诊断敏感度(75.9% 升至 87.9%),同时保持较高特异度(87.5% 与 86.2%)。
要点
- 主要征象中动脉期高强化敏感度最高(88.5%),包膜特异度最高(98.8%)。
- 联合主要与辅助征象后 LR-4/5/5V 敏感度由 75.9% 升至 87.9%。
- LR-5 或 LR-5V 类别诊断肝细胞癌特异度达 95.8%。
核心结论
- 联合应用辅助征象与主要征象可在保持高特异度的同时提高肝细胞癌诊断敏感度。
研究设计与样本
- 回顾性、经机构审查委员会批准的研究,纳入 2004 至 2016 年间 102 例有肝脏 MR 成像且至少一个病灶经病理证实的患者,共 275 个观察病灶(含 113 个肝细胞癌),由两名放射科医师独立评估。
关键影像表现/征象
- 主要征象动脉期高强化敏感度 88.5%、特异度 18.6%。
- 主要征象廓清敏感度 60.6%、特异度 84.8%。
- 主要征象包膜敏感度 32.9%、特异度 98.8%。
- 主要征象阈值增长敏感度 41.6%、特异度 83.2%。
诊断标准与关键数值
- 辅助征象轻度-中度 T2 高信号敏感度 62.2%、特异度 79.4%。
- 辅助征象弥散受限敏感度 54.8%、特异度 90.6%。
- 辅助征象马赛克结构敏感度 9.9%、特异度 99.4%。
- 辅助征象病灶内脂肪敏感度 30.9%、特异度 94.2%。
- 辅助征象病灶脂肪保留敏感度 23.1%、特异度 83.1%;血液产物敏感度 2.8%、特异度 99.3%;亚阈值增长敏感度 48.3%、特异度 91.4%。
临床应用与阅片要点
- LR-5 或 LR-5V 类别诊断肝细胞癌的每病灶敏感度 50.8%、特异度 95.8%。
- 仅用主要征象判定 LR-4、LR-5 或 LR-5V 时每病灶敏感度 75.9%、特异度 87.5%。
- 联合主要与辅助征象判定 LR-4、LR-5 或 LR-5V 时每病灶敏感度 87.9%、特异度 86.2%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To evaluate the performance of major features, ancillary features, and categories of Liver Imaging Reporting and Data System (LI-RADS) version 2014 at magnetic resonance (MR) imaging for the diagnosis of hepatocellular carcinoma (HCC). Materials and Methods This retrospective institutional review board-approved study included patients with liver MR imaging and at least one pathologically proved lesion. Between 2004 and 2016, 102 patients (275 observations including 113 HCCs) met inclusion criteria. Two radiologists independently assessed major and ancillary imaging features for each liver observation and assigned a LI-RADS category. Per-lesion estimates of diagnostic performance of major features, ancillary features, and LI-RADS categories were assessed by using generalized estimating equation models. Results Major features (arterial phase hyperenhancement, washout, capsule, and threshold growth) had a sensitivity of 88.5%, 60.6%, 32.9%, and 41.6%, and a specificity of 18.6%, 84.8%, 98.8%, and 83.2% for HCC, respectively. Ancillary features (mild-moderate T2 hyperintensity, restricted diffusion, mosaic architecture, intralesional fat, lesional fat sparing, blood products, and subthreshold growth) had a sensitivity of 62.2%, 54.8%, 9.9%, 30.9%, 23.1%, 2.8%, and 48.3%, and a specificity of 79.4%, 90.6%, 99.4%, 94.2%, 83.1%, 99.3%, and 91.4% for HCC, respectively. The LR-5 or LR-5 V categories had a per-lesion sensitivity of 50.8% and a specificity of 95.8% for HCC, respectively. The LR-4, LR-5, or LR-5 V categories (determined by using major features only vs combination of major and ancillary features) had a per-lesion sensitivity of 75.9% and 87.9% and a per-lesion specificity of 87.5% and 86.2%, respectively. Conclusion The use of ancillary features in combination with major features increases the sensitivity while preserving a high specificity for the diagnosis of HCC.
引用
- Cerny M, Bergeron C, Billiard JS, et al. LI-RADS for MR Imaging Diagnosis of Hepatocellular Carcinoma: Performance of Major and Ancillary Features. Radiology. 2018. PMID: 29634435. doi:10.1148/radiol.2018171678
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。